Depomed signs licensing agreements with Covidien and Solvay
This article was originally published in Scrip
Executive Summary
Depomed has signed licensing agreements with the Covidiensubsidiary Mallinckrodt, involving the use of Depomed's AcuForm technology for the exclusive development of four undisclosed products.